CLINICAL TRIALS PROFILE FOR ASP8062
Clinical Trials for ASP8062
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT03092726 ↗ | A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia | Completed | Astellas Pharma Global Development, Inc. | Phase 2 | The purpose of this study was to assess analgesic efficacy of ASP8062 relative to placebo as well as the safety and tolerability. This study also assessed the treatment differences in physical function as well the improvements in overall subject status (e.g., fibromyalgia symptoms, global functioning) of ASP8062 relative to placebo. |
| NCT03183739 ↗ | Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects | Completed | Astellas Pharma Inc | Phase 1 | The purpose of this study is to evaluate the safety and tolerability and evaluate pharmacokinetics of single and multiple ascending oral doses of ASP8062 in nonelderly Japanese male and female subjects. |
| NCT04003402 ↗ | A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects | Completed | Astellas Pharma Global Development, Inc. | Phase 1 | The purpose of this study is to assess the potential for pharmacokinetic (PK) and pharmacodynamics (PD) interactions between ASP8062 and alcohol. This study will also assess safety and tolerability of a single dose of ASP8062 with or without alcohol. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for ASP8062
Condition Name
Clinical Trial Locations for ASP8062
Trials by Country
Clinical Trial Progress for ASP8062
Clinical Trial Phase
Clinical Trial Sponsors for ASP8062
Sponsor Name
